India has risen to the eighth position globally in WHO pharmacovigilance contributions, according to statements by Health Minister J. P. Nadda during the Indian Pharmacopoeia 2026 release. The minister noted India's ascent from 123rd a decade ago and highlighted the addition of 121 new monographs in IP 2026, bringing the total to 3,340. PvPI progress covers key therapeutic areas such as anti-tubercular, anti-diabetic, and anti-cancer medicines, and the Indian Pharmacopoeia's global acceptance has expanded to 19 Global South countries. The government cites strengthened drug regulation, reporting, and quality standards as drivers of this improvement in patient safety and governance.
India: 8th in WHO pharmacovigilance contributions
IP 2026 adds 121 monographs (total 3,340)
PvPI growth includes TB, diabetes, cancer medicines
Global South acceptance: 19 countries
Driven by stronger regulation and reporting
Jan 03, 2026
Karnataka Sets Record with 198 Organ Donations in 2025
Karnataka has recorded its highest-ever organ donation figures with 198 donations in 2025, setting a new milestone in the state's transplant history.
This has surpassed the previous record registered in 2023, when the state reported 178 organ donations.
According to health department, with this achievement, Karnataka has secured the third position nationally in organ donations for 2025, setting a milestone for the State Organ and Tissue Transplant Organisation (SOTTO).
Among the States, Tamil Nadu topped the chart with 267 organ donations, followed by Telangana with 205. Karnataka stood third with 198 donations, while Maharashtra and Gujarat reported 153 and 152 donations respectively, according to official data.
Jan 01, 2026
Abu Dhabi Hospital First to Administer ITVISMA for SMA
Abu Dhabi’s Sheikh Khalifa Medical City became the first hospital globally to administer ITVISMA, a one-time gene therapy for spinal muscular atrophy (SMA). The treatment was delivered in December 2025 under the supervision of the Department of Health, Abu Dhabi. Developed by Novartis, ITVISMA replaces the defective SMN1 gene to enable production of the survival motor neuron protein. The therapy is approved for patients two years and older, including adults, expanding access beyond infant-only treatment. The milestone highlights advances in precision medicine and international collaboration in genetic therapies.
First global administration of ITVISMA for SMA at Sheikh Khalifa Medical City.
Delivery occurred in December 2025 under DOH supervision.
ITVISMA replaces defective SMN1 gene; targets SMA root cause.
Single-dose therapy approved for patients aged two years and above.
Dec 31, 2025
IGNOU Launches MSc in Data Science & Analytics
The Indira Gandhi National Open University (IGNOU) has launched a Master of Science (MSc) in Data Science and Analytics under the Open Distance Learning (ODL) mode. Offered through the School of Computer and Information Sciences (SOCIS), the two-year degree aims to meet rising demand for data-driven professionals across sectors. The programme is open to learners from varied backgrounds, including those seeking to upgrade skills or shift into data science careers. It focuses on computational methods, statistics, and practical data projects, with online and on-campus support to widen access to higher education.
MSc in Data Science & Analytics launched under ODL mode.
Program by IGNOU’s SOCIS; two-year degree.
Open to varied academic backgrounds.
Emphasis on computational methods, statistics, and projects.
Aims to expand access to data science careers.
Dec 30, 2025
India’s First PPP Medical Colleges to Start in MP Tribal Districts
India will establish its first Public-Private Partnership (PPP) model medical colleges in Madhya Pradesh’s tribal districts Dhar and Betul. The foundation stone ceremony, attended by Health Minister and Chief Minister, marked the project as part of broader reforms to expand medical education through PPPs. The plan includes two more PPP medical colleges in Katni and Panna, with a wider strategy to improve access to clinical training and healthcare in tribal regions. The initiative aims to raise local healthcare standards and provide opportunities for aspiring medical professionals in underserved areas.
First PPP medical colleges planned in MP’s Dhar and Betul
Foundation stones laid in December 2025
Two more PPP colleges planned for Katni and Panna
Aims to improve medical education and healthcare access
Part of broader reforms to engage private sector in medical education
Sharadchandra Pawar Centre of Excellence in Artificial Intelligence Inaugurated in Baramati
Industrialist Gautam Adani inaugurated the Sharadchandra Pawar Centre of Excellence in Artificial Intelligence in Baramati, Maharashtra, in December 2025. The centre supports India’s AI ecosystem and higher education infrastructure, built under Vidya Pratishthan and fully funded by the Adani Group chair. The initiative emphasizes collaboration between industry and academia to prepare youth for emerging technologies such as AI, data science and machine learning. The facility aims to foster research, innovation and skilled workforce development for regional and national growth.
Centre of Excellence in AI inaugurated in Baramati
Funded by the Adani Group chair; run under Vidya Pratishthan